Clinical analysis of aspirin and ursodeoxycholic acid on treating intrahepatic cholestasis of pregnancy
10.3760/cma.j.issn.1673-4904.2012.19.008
- VernacularTitle:阿司匹林与熊去氧胆酸治疗妊娠期肝内胆汁淤积症临床分析
- Author:
Wei MENG
;
Huijun WANG
;
Chunzhong DONG
- Publication Type:Journal Article
- Keywords:
Aspirin;
Ursodeoxycholic acid;
Cholestasis,intrahepatic
- From:
Chinese Journal of Postgraduates of Medicine
2012;35(19):23-25
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effect of aspirin and ursodeoxycholic acid on treating intrahepatic cholestasis of pregnancy (ICP).Methods Seventy-one ICP patients were divided by random digits table method into observation group (36 cases) and contol group (35 cases).Observation group was treated with aspirin and ursodeoxycholic acid.Control group was given unsodeoxycholic acid.The biochemical indicators,itching score and pregnancy outcomes of two groups were observed.Results Total bile acid (TBA),total bilirubin (TBIL),alanine aminotransferase(ALT),aspartate aminotransferase(AST)and itching score of two groups after treatment were all significantly lower than those before treatment (P ＜0.05 ).TBA,TBIL,ALT and itching score of observation group[ (31.7 ± 8.3 ) μ mol/L,(33.9 ± 5.8 ) μ mol/L,(53.1 ± 8.4) U/L,(0.48 ± 0.06) scores] were obviously lower than those of control group [(76.2 ±9.2)μ mol/L,(56.9 ± 8.2) μmol/L,(80.8 ± 10.6) U/L,(0.81 ±0.04) scores] (P ＜0.05).The incidences of amniotic fluid contamination,premature delivery and neonatal asphyxia of observation group were significantly lower than those of control group [38.9％(14/36) vs.71.4％(25/35),11.1％(4/36) vs.31.4％( 11/35 ),5.6％ ( 2/36 ) vs.22.9％ ( 8/35 ),P ＜ 0.05 ].Conclusions The combined application of aspirin and ursodeoxycholic acid can improve the biochemical indicators,itching symptom and pregnancy outcomes.
